Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Assets Average (2020 - 2025)

Benitec Biopharma's Assets Average history spans 4 years, with the latest figure at $24.2 million for Q4 2023.

  • For Q4 2023, Assets Average changed N/A year-over-year to $24.2 million; the TTM value through Dec 2023 reached $24.2 million, changed N/A, while the annual FY2024 figure was $28.3 million, 443.01% up from the prior year.
  • Assets Average for Q4 2023 was $24.2 million at Benitec Biopharma, up from $15.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $24.2 million in Q4 2023 and bottomed at $10.3 million in Q3 2020.
  • The 4-year median for Assets Average is $14.5 million (2021), against an average of $15.2 million.
  • The largest YoY upside for Assets Average was 30.84% in 2023 against a maximum downside of 30.84% in 2023.
  • A 4-year view of Assets Average shows it stood at $12.2 million in 2020, then surged by 42.49% to $17.4 million in 2021, then crashed by 30.8% to $12.0 million in 2022, then surged by 100.95% to $24.2 million in 2023.
  • Per Business Quant, the three most recent readings for BNTC's Assets Average are $24.2 million (Q4 2023), $15.8 million (Q3 2023), and $12.0 million (Q3 2022).